Michael Henderson - Jul 13, 2023 Form 3/A - Amendment Insider Report for Apogee Therapeutics, Inc. (APGE)

Role: Chief Executive Officer, Director
Signature: /s/ Jane Pritchett Henderson, as attorney-in-fact for Michael Henderson
Stock symbol: APGE
Transactions as of: Jul 13, 2023
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 7/17/2023, 05:04 PM
Date Of Original Report: Jul 13, 2023
Previous filing: Jun 30, 2023
Next filing: Dec 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	APGE	Common Stock						1.49M	Jul 13, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 851,495 shares of restricted common stock, which vest in 34 equal monthly installments through May 2, 2026, and (ii) 287,377 shares of restricted common stock, one quarter of which will vest on December 14, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, in each case subject to the Reporting Person's continued service to the Issuer.
F2	This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.

Content

Includes (i) 851,495 shares of restricted common stock, which vest in 34 equal monthly installments through May 2, 2026, and (ii) 287,377 shares of restricted common stock, one quarter of which will vest on December 14, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, in each case subject to the Reporting Person's continued service to the Issuer.

This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.